These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3876993)

  • 1. Suppressor factor of T-cell activation and decreased interleukin 2 activity in experimental African trypanosomiasis.
    Alcina A; Fresno M
    Infect Immun; 1985 Nov; 50(2):382-7. PubMed ID: 3876993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor macrophages in Trypanosoma brucei infection: nitric oxide is related to both suppressive activity and lifespan in vivo.
    Mabbott NA; Sutherland IA; Sternberg JM
    Parasite Immunol; 1995 Mar; 17(3):143-50. PubMed ID: 7792098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma brucei infection elicits nitric oxide-dependent and nitric oxide-independent suppressive mechanisms.
    Beschin A; Brys L; Magez S; Radwanska M; De Baetselier P
    J Leukoc Biol; 1998 Apr; 63(4):429-39. PubMed ID: 9544572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection.
    Sternberg J; McGuigan F
    Eur J Immunol; 1992 Oct; 22(10):2741-4. PubMed ID: 1396977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active suppression of interleukin 2 secretion in mice infected with Trypanosoma brucei AnTat 1.1.E.
    Sileghem M; Hamers R; De Baetselier P
    Parasite Immunol; 1986 Nov; 8(6):641-9. PubMed ID: 2880330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cells in mice infected with Trypanosoma brucei.
    Eardley DD; Jayawardena AN
    J Immunol; 1977 Sep; 119(3):1029-33. PubMed ID: 302268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive macrophages occurring in murine Trypanosoma brucei infection inhibit T-cell responses in vivo and in vitro.
    Borowy NK; Sternberg JM; Schreiber D; Nonnengasser C; Overath P
    Parasite Immunol; 1990 May; 12(3):233-46. PubMed ID: 2143570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased interleukin-2 responsiveness in leukocytes from Trypanosoma brucei-infected mice.
    Bowlin TL; Bitonti AJ; McKown BJ
    Cell Immunol; 1988 Apr; 112(2):437-41. PubMed ID: 3128404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-gamma are synergistic inducers of nitric oxide synthase.
    Sternberg MJ; Mabbott NA
    Eur J Immunol; 1996 Mar; 26(3):539-43. PubMed ID: 8605918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction of suppressor cells by plasma of rats with Trypanosoma brucei rhodesiense infection.
    Hayes MM; Cox HW
    J Parasitol; 1986 Feb; 72(1):148-54. PubMed ID: 2940354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte requirement for the induction of mouse macrophage procoagulant activity by Trypanosoma brucei.
    Rossi BC; Dean RT; Terry RJ
    Parasite Immunol; 1987 Nov; 9(6):697-704. PubMed ID: 3501564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon.
    Darji A; Sileghem M; Heremans H; Brys L; De Baetselier P
    Infect Immun; 1993 Jul; 61(7):3098-102. PubMed ID: 8514421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine model study of the practical implication of trypanosome-induced immunosuppression in vaccine-based disease control programmes.
    Onah DN; Wakelin D
    Vet Immunol Immunopathol; 2000 May; 74(3-4):271-84. PubMed ID: 10802294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte system and relative resistance of inbred mice to Trypanosoma brucei brucei].
    Makumyaviri AM; Sileghem M; Le Ray D; Hamers R; de Baetselier P
    Ann Inst Pasteur Immunol; 1988; 139(5):545-56. PubMed ID: 2905137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cells in Trypanosoma congolense-infected mice.
    Pearson TW; Roelants GE; Lundin LB; Mayor-Withey KS
    Adv Exp Med Biol; 1979; 114():655-60. PubMed ID: 313686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
    Sacco RE; Hagen M; Donelson JE; Lynch RG
    J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B Cells.
    Frenkel D; Zhang F; Guirnalda P; Haynes C; Bockstal V; Radwanska M; Magez S; Black SJ
    PLoS Pathog; 2016 Jul; 12(7):e1005733. PubMed ID: 27403737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte function in experimental african trypanosomiasis: mitogenic effects of trypanosome extracts in vitro.
    Mansfield JM; Craig SA; Stelzer GT
    Infect Immun; 1976 Oct; 14(4):976-81. PubMed ID: 992878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-infection with Trypanosoma brucei brucei prevents experimental autoimmune encephalomyelitis in DBA/1 mice through induction of suppressor APCs.
    Wållberg M; Harris RA
    Int Immunol; 2005 Jun; 17(6):721-8. PubMed ID: 15899926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine T lymphocyte specificity for African trypanosomes. II. Suppression of the T lymphocyte proliferative response to Trypanosoma brucei by systemic trypanosome infection.
    Gasbarre LC; Hug K; Louis J
    Clin Exp Immunol; 1981 Jul; 45(1):165-72. PubMed ID: 6458434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.